-20℃ 3 years powder
-80℃ 2 years in solvent
TAK-779 is an antagonist of chemokine receptor 5 (CCR5), CCR2b, and CXC chemokine receptor 3 (CXCR3).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | 75.00 | |
5 mg | In stock | 107.00 | |
10 mg | In stock | 195.00 | |
25 mg | In stock | 351.00 | |
50 mg | In stock | 527.00 | |
1 mL * 10 mM (in DMSO) | In stock | 203.00 |
Description | TAK-779 is an antagonist of chemokine receptor 5 (CCR5), CCR2b, and CXC chemokine receptor 3 (CXCR3). |
Targets&IC50 | Abl :ic50 14nM, Abl (T315I) :ic50 4nM, Aurora A :ic50 48nM, FGFR1 :ic50 36nM, FLT3 :ic50 6.6nM, FLT3 (D835Y) :ic50 1nM, JAK2 :ic50 150nM, Kit :ic50 300nM, Src :ic50 400nM, MIP-1α-CCR5 :ic50 1 nM (in CHO/CCR5 cells), MIP-1β-CCR5 :ic50 1 nM (in CHO/CCR5 cells), RANTES-CCR5 :ic50 1.4 nM (in CHO/CCR5 cells), MCP-1-CCR2b :ic50 27 nM (in CHO/CCR5 cells), R5 HIV-1 (Ba-L) :ic50 3.7 nM (EC50, in PBMCs), R5 HIV-1 (KK) :ic50 1.6 nM (EC50, in PBMCs), CCR2;CXCR, |
In vivo | TAK-779 increases intestinal allograft survival in a rat model of small intestine transplantation when administered at a dose of 10 mg/kg per day[2]. |
Kinase Assay | FLT3 phosphorylation: Leukemia cells are washed in phosphate-buffered saline (PBS), then lysed by resuspending the cells in lysis buffer (20 mM Tris pH 7.4, 100 mM NaCl, 1% Igepal, 1 mM EDTA, 2 mM NaVO4, plus Complete protease inhibitor KW-2449 for 30 minutes while rocking. The extract is clarified by centrifugation at 1.6 × 104 g and the supernatant is assayed for protein (Bio-Rad). A 50-μg aliquot is removed as a whole-cell lysate for analysis of STAT5, and the remainder is used for immunoprecipitation with anti-FLT3. Anti-FLT3 antibody is added to the extract for overnight incubation, then protein A sepharose is added for 2 additional hours. Separate sodium dodecyl sulfate–polyacrylamide electrophoresis (SDS-PAGE) gels for whole-cell lysate and immunoprecipates are run in parallel. After transfer to Immobilon membranes, immunoblotting is performed with antiphosphotyrosine antibody (4G10) to detect phosphorylated FLT3 or, for the whole-cell lysate gels, with a rat monoclonal antibody against phosphorylated STAT5 (residue Y694) then stripped and reprobed with anti-FLT3 antibody to measure total FLT3. Proteins are visualized using chemiluminescence, exposed on Kodak BioMax XAR film, developed, and scanned using a Bio-Rad GS800 densitometer. The concentration of KW-2449 for which the phosphorylation of FLT3 or STAT5 is inhibited to 50% of its baseline (IC50) is determined using linear regression analysis of the dose response curves. For direct analysis of FLT3 and STAT5 in circulating blasts, peripheral blood is collected in heparinized tubes and promptly chilled on ice. Samples are centrifuged for 10 minutes at 900 g, at 4 °C. The plasma is removed and stored frozen at −80 °C. The buffy coat is carefully transferred to ice-cold PBS, layered onto chilled Ficoll-Hypaque, and centrifuged for 5 minutes at 600 g, at 4 °C. All subsequent steps are carried out at 4 °C. Mononuclear cells are collected and washed rapidly once in red blood cell lysis buffer (0.155 M NH4Cl, 0.01 M KHCO3, 0.1 mM EDTA), then washed once in PBS. Cells are then lysed as described for FLT3 and STAT5 analysis. |
Cell Research |
Cell viability is determined by the sodium 3′-[1-(phenylaminocarbonyl)-3, 4-tetrazolium]-bis (4-methoxy-6-nitro) benzene sulfonic acid hydrate assay after incubation with or without KW-2449 for 72 hours at 37 °C. The number of viable cells is determined using the Cell Proliferation Kit II. For cell-cycle analysis, MOLM-13 and RS4;11 cells are treated with KW-2449. After 24, 48, and 72 hours of incubation at 37 °C, DNA contents are analyzed. Cell cycle distribution of K562, TCC-Y, and TCC/Ysr is analyzed 24 hours after treatment with KW-2449 or imatinib. (Only for Reference)
Cell lines: MOLM-13 and RS4;11 cells
|
Animal Research |
Animal Model: CBySmn.CB17-Prkdsscid/J (BALB/C) mice are injected with BV173/E255K/Luc cl4 cells.
|
Synonyms | Takeda 779 |
Purity | 98.00% |
Molecular Weight | 531.13 |
Formula | C33H39ClN2O2 |
CAS No. | 229005-80-5 |
-20℃ 3 years powder
-80℃ 2 years in solvent
DMSO: 25 mg/mL (47.07 mM)
Ethanol: 62 mg/mL (186.5 mM)
Water: <1 mg/mL
H2O: 16.66 mg/mL (31.37 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
0.5% methylcellulose: 30 mg/mL
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.